Any use outside the FDA-approved indication is considered off-label and should involve informed consent, individualized evaluation, and ongoing medical monitoring
Bill Forster, a retired Cambridge Education Association member, helped rally retiree opposition to the proposed cuts
If we have an idea that can both work in diabetes in a much safer way than in insulin, and then also at the same time work in obesity
The SUSTAIN clinical trial program provides extensive evidence for diabetes management
BPC-157: The "Body Protection Compound" BPC-157 is derived from a natural protein found in the stomach
Theoretically, yes, you can take a break from Wegovy, but its unlikely to be recommended by clinicians as youd need to drop back down to the lowest dose should you decide to go back on the medication